Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 30;30(24):2867-80.
doi: 10.1002/sim.4322. Epub 2011 Aug 4.

Subgroup identification from randomized clinical trial data

Jared C Foster  1 , Jeremy M G Taylor, Stephen J Ruberg
Affiliations

Subgroup identification from randomized clinical trial data

Jared C Foster et al. Stat Med. .

Abstract

We consider the problem of identifying a subgroup of patients who may have an enhanced treatment effect in a randomized clinical trial, and it is desirable that the subgroup be defined by a limited number of covariates. For this problem, the development of a standard, pre-determined strategy may help to avoid the well-known dangers of subgroup analysis. We present a method developed to find subgroups of enhanced treatment effect. This method, referred to as 'Virtual Twins', involves predicting response probabilities for treatment and control 'twins' for each subject. The difference in these probabilities is then used as the outcome in a classification or regression tree, which can potentially include any set of the covariates. We define a measure Q(Â) to be the difference between the treatment effect in estimated subgroup  and the marginal treatment effect. We present several methods developed to obtain an estimate of Q(Â), including estimation of Q(Â) using estimated probabilities in the original data, using estimated probabilities in newly simulated data, two cross-validation-based approaches, and a bootstrap-based bias-corrected approach. Results of a simulation study indicate that the Virtual Twins method noticeably outperforms logistic regression with forward selection when a true subgroup of enhanced treatment effect exists. Generally, large sample sizes or strong enhanced treatment effects are needed for subgroup estimation. As an illustration, we apply the proposed methods to data from a randomized clinical trial.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ruberg SJ, Chen L, Wang Y. The mean doesn’t mean as much anymore: Finding sub-groups for tailored therapeutics. Clinical Trials. 2010;7:574–583. - PubMed
    1. Assmann SF, Pocock SJ, Enos LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. The Lancet. 2000;355:1064–1069. - PubMed
    1. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Smith GD. Subgroup analyses in randomized controlled trials: quantifying the risks of false-positives and false-negatives. Health Technology Assessment. 2001;5(33):1–56. - PubMed
    1. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Oncol. 2004;57:229–236. - PubMed
    1. Cui L, Hung HMJ, Wang SJ, Tsong Y. Issues related to subgroup analysis in clinical trials. J Biopharmaceutical Statistics. 2002;12(3):347–358. - PubMed

Publication types